Antiolip

Антиолип

About the product

Trade name: Antiolip

Dosage form: capsules

Ingredients: Red Yeast Rice powder (monacolin 1.5%) – 167 mg, Japanese Knotweed extract (polydatin 98%) – 40 mg, Japanese Knotweed extract (trans-resveratrol 98%) – 40 mg, Black Garlic extract (polyphenols 1%) – 20 mg, lactose monohydrate (carrier) – 159 mg, microcrystalline cellulose (carrier) – 20 mg, magnesium stearate (anticaking agent) – 4 mg, capsule shell: bovine and/or porcine gelatin (up to 100%) – 118 mg

For the patient

Dietary supplement: "Antiolip"

Indications for use:

  • Strengthens the immune system and protects cells from premature aging
  • Supports cardiovascular health
  • Helps normalize blood sugar and cholesterol levels
  • Improves digestion and intestinal function

Consultation with a healthcare professional is recommended before use

Contraindications:

  • Individual intolerance to the components
  • Pregnancy
  • Breastfeeding

Contact us

Select a service*

Pharmacovigilance

MiraxBioPharma is committed to ensuring the quality and safety of its products and pays special attention to collecting and analyzing information about adverse reactions and complaints associated with the use of our products.

If you become aware of any adverse reactions to the medicinal product Cezarox® Epi or of a lack of therapeutic effect, please report it via email at: adversareaction@drugsafety.ru or by phone: +7 (800) 777-86-04.

If you become aware of any adverse reactions to other MiraxBioPharma medicinal products or of a lack of therapeutic effect, please report it via email at: GVP@mbpharma.ru, by phone: +7 (495) 183-38-41 or by filling out the electronic form below

Adverse reaction reporting form
Specify gender*
Suspected medicinal product information
Reporter information

Preferred method of contact*
We use cookies

By using this website, you consent to the collection and processing of your personal data, including through third-party services, and the use of cookies and web analytics tools, under the terms outlined in the Personal Data Processing Policy.